Skip to content

An Analysis of Presentation and Outcome Following Treatment of Pancreatic Endocrine Neoplasms

A Single Centre Analysis of Clinical Characteristics and Treatment of Endocrine Pancreatic Tumours.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02400996
Enrollment
40
Registered
2015-03-27
Start date
2011-03-31
Completion date
2014-11-30
Last updated
2015-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic Endocrine Neoplasms

Keywords

Endocrine Pancreas, Pancreatic Endocrine Neoplasm

Brief summary

A single institutional study of Pancreatic Endocrine Neoplasms over 18 years.

Detailed description

The investigators did an analysis from a prospectively maintained database of patients who underwent pancreatic resections or nonresective procedures for neoplasms of the pancreas at Sir Ganga Ram Hospital from 1995 to 2013 and using pathological reports and preoperative CT scan as the gold standard, the investigators identified 40 patients with PENs.

Interventions

None listed

Sponsors

Sir Ganga Ram Hospital
CollaboratorOTHER
Medical College and Hospital Kolkata
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Pathological reports and Prooperative CAT Scan showing Endocrine Pancreatic Tumours

Exclusion criteria

* Nonendocrine Pancreatic Tumours

Design outcomes

Primary

MeasureTime frameDescription
Nonfunctioning and Malignant Pancreatic Endocrine NeoplasmsEach participant was followed up for a period of 5 yearsOf the 40 patients operated for Pancreatic Endocrine Neoplasms, using clinical criteria, histopathological analysis and preoperative imaging as gold standard, nonfunctioning and functioning tumours were identified. Similarly the number of benign and malignant lesions identified were recorded as per the WHO Classification of pancreatic endocrine tumours.

Participant flow

Recruitment details

An analysis from a prospectively maintained database of patients was done who underwent pancreatic surgery for neoplasms of the pancreas at Sir Ganga Ram Hospital, New Delhi, India from 1995 to 2013 and using pathological reports and preoperative CT scan as gold standard, we identified 40 patients with PENs

Participants by arm

ArmCount
Patients Operated for Pancreatic Endocrine Neoplasms
We did an observational analysis from a prospectively maintained database of patients who underwent pancreatic surgery for neoplasms of the pancreas at Sir Ganga Ram Hospital, New Delhi, India from 1995 to 2013 and using pathological reports and preoperative CT scan as gold standard, we identified 40 patients with PENs.
40
Total40

Baseline characteristics

CharacteristicPatients Operated for Pancreatic Endocrine Neoplasms
Age, Continuous48.6 years
STANDARD_DEVIATION 15.52
Region of Enrollment
India
40 participants
Sex: Female, Male
Female
18 Participants
Sex: Female, Male
Male
22 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
16 / 40
serious
Total, serious adverse events
6 / 40

Outcome results

Primary

Nonfunctioning and Malignant Pancreatic Endocrine Neoplasms

Of the 40 patients operated for Pancreatic Endocrine Neoplasms, using clinical criteria, histopathological analysis and preoperative imaging as gold standard, nonfunctioning and functioning tumours were identified. Similarly the number of benign and malignant lesions identified were recorded as per the WHO Classification of pancreatic endocrine tumours.

Time frame: Each participant was followed up for a period of 5 years

ArmMeasureGroupValue (NUMBER)
Patients Operated for Pancreatic Endocrine NeoplasmsNonfunctioning and Malignant Pancreatic Endocrine NeoplasmsNonfunctioning Tumours28 participants
Patients Operated for Pancreatic Endocrine NeoplasmsNonfunctioning and Malignant Pancreatic Endocrine NeoplasmsFunctioning Tumours12 participants
Patients Operated for Pancreatic Endocrine NeoplasmsNonfunctioning and Malignant Pancreatic Endocrine NeoplasmsBenign Tumours22 participants
Patients Operated for Pancreatic Endocrine NeoplasmsNonfunctioning and Malignant Pancreatic Endocrine NeoplasmsMalignant Tumours18 participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026